By the end of this month, AstraZeneca’s heart disease drug Brilinta is expected to hit the pharmacies. The US Food and Drug Administration has...
In a new study recently conducted by the British multinational pharmaceutical and biologics company AstraZeneca on their new anti-clotting drug known as...